During a transurethral resection of the prostate (TURP), the most established surgical treatment of symptoms due to benign prostatic hyperplasia, the prostate can bleed profusely, bringing about anemia and compromised oxygen delivery to the entire body.

The primary purpose of the newly published study from Fredrik Stenmark and co-workers was to assess the efficacy of mepivacaine and adrenaline, injected into the prostate using Schelin Catheter, on bleeding. The so-called primary endpoint was to measure blood loss per resected weight of prostate tissue. The study, which was both randomized and controlled, evaluated 81 patients randomly assigned to standard TURP or TURP by intraprostatic injections using Schelin Catheter. The authors conclude that it is beneficial to administer intraprostatic injections of mepivacaine/adrenaline in immediate conjunction with TURP, in terms of blood loss per resected gram. They also believe that the positive results of the study, along with the low frequency of complications, further underscore the importance of their report.

Johan Wennerholm, CEO ProstaLund: "It is very gratifying that the previous hypothesis, that Schelin Catheter can be used to administer adrenaline to the prostate in order to reduce one of the biggest problems with TURP, is now confirmed in this way. Considering that TURP is by far the most common surgical method worldwide, the potential for Schelin Catheter is enormous. Virtually the entire world's urologists is served by our tool."

[1] https://doi.org/10.2340/sju.v58.7798